Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab, quantity: 1800 mg - injection, solution - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride monohydrate; sorbitol; methionine; polysorbate 20; water for injections - darzalex sc is indicated for the treatment of patients:,? with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. for use in combination with:-bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. for use in combination with: - bortezomib, melphalan and prednisone, or - lenalidomide and dexamethasone.,? with multiple myeloma who have received: - at least one prior therapy. for use in combination with: - bortezomib and dexamethasone, or - lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (pi) and an immunomodulatory agent or who are refractory to both a pi and an immunomodulatory agent. for use as: - monotherapy.,darzalex sc in combination with bortezomib, cyclophosphamide and dexamethasone, is indicated for the treatment of patients with light chain al amyloidosis.

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: pnf pharmaceutical, inc. :; distributor: multicare pharmaceuticals phils., inc. - insulin human (rdna) - suspension for injection (im/sc) - 100 iu/ml suspension for injection (im/sc) (30% soluble insulin human / 70% isophane insulin human)

United Kingdom - English - myHealthbox

bayer ag -

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - tocilizumab, quantity: 162 mg - injection, solution - excipient ingredients: polysorbate 80; arginine hydrochloride; methionine; histidine; histidine hydrochloride monohydrate; water for injections - rheumatoid arthritis (iv and sc formulations),actemra is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients in combination with methotrexate (mtx) or other non-biological disease-modifying anti-rheumatic drugs (dmards) in case of either an inadequate response or intolerance to previous therapy with one or more dmards.,actemra is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients with poor prognostic factors (see section 5.1 pharmacodynamic properties, clinical trials) in combination with mtx in those not previously treated with mtx.,in the two groups of patients above, actemra can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate.,actemra has been shown to inhibit the progression of joint damage in adults, as measured by x-ray, when given in combination with methotrexate.,giant cell arteritis (sc formulations only),actemra is indicated for the treatment of giant cell arteritis (gca) in adult patients.,polyarticular juvenile idiopathic arthritis (iv and sc formulations),actemra is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to or intolerance to methotrexate (mtx). actemra can be given alone or in combination with mtx.,systemic juvenile idiopathic arthritis (iv and sc formulations),intravenous formulation,actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.,subcutaneous formulation,actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 1 year of age and older.,actemra iv and sc can be given alone or in combination with methotrexate (mtx).

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - tocilizumab, quantity: 162 mg - injection, solution - excipient ingredients: polysorbate 80; arginine hydrochloride; methionine; histidine; histidine hydrochloride monohydrate; water for injections - rheumatoid arthritis (iv and sc formulations),actemra is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients in combination with methotrexate (mtx) or other non-biological disease-modifying anti-rheumatic drugs (dmards) in case of either an inadequate response or intolerance to previous therapy with one or more dmards.,actemra is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients with poor prognostic factors (see section 5.1 pharmacodynamic properties, clinical trials) in combination with mtx in those not previously treated with mtx.,in the two groups of patients above, actemra can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate.,actemra has been shown to inhibit the progression of joint damage in adults, as measured by x-ray, when given in combination with methotrexate.,giant cell arteritis (sc formulations only),actemra is indicated for the treatment of giant cell arteritis (gca) in adult patients.,polyarticular juvenile idiopathic arthritis (iv and sc formulations),actemra is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to or intolerance to methotrexate (mtx). actemra can be given alone or in combination with mtx.,systemic juvenile idiopathic arthritis (iv and sc formulations),intravenous formulation,actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.,subcutaneous formulation,actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 1 year of age and older.,actemra iv and sc can be given alone or in combination with methotrexate (mtx).

Philippines - English - FDA (Food And Drug Administration)

pharmastar international trading corp.; distributor: pharmastar international trading corp. - heparin sodium - solution for injection (iv/sc) - 5000 iu/ml solution for injection (iv/sc)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - epoxiconazole - suspension concentrate - epoxiconazole ungrouped active 125.0 g/l - fungicide - barley | wheat - leaf rust | leaf rust - puccinia hordei | septoria nodorum blotch on wheat | stripe rust | puccinia recondita f.sp. triti | puccinia triticina | wheat leaf rust | yellow rust

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - simazine - suspension concentrate - simazine triazine active 500.0 g/l - herbicide - almond over 3 years old | apple | asparagus | canola - see label | chickpea | citrus over 1 year old | currant over 1 year old | - annual ryegrass | annual ryegrass - suppression | annual thistle | barley grass | barley grass - suppression | bindy-eye | black bindweed - suppression | brome grass | brome grass - suppression | capeweed | cereal - self-sown | charlock | chickweed | clover | corn gromwell, ironweed or sheepweed | creeping oxalis | deadnettle | dock | fat hen | fumitory | geranium | hedge or wild mustard | indian hedge mustard | ivy leaf speedwell | lesser swinecress or bittercress | london rocket | mustard | nettle | paterson's curse | potato or yellow weed | powell's amaranth | prickly lettuce | purple goosefoot | radish | redroot or redroot amaranth | redshank | redshank,slim or spleen amaranth | ryegrass - suppression | sand fescue | shepherd's purse | silver grass or rat's-tail fescue | silvergrass - vulpia spp. | soursob or oxalis | soursob or oxalis - suppression | sow or milk thistle | squirrel-tail fescue or silver grass | three cornered jack or doublegee | turnip | turnip weed | wild oat | wild oat - suppression | w

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - azoxystrobin - suspension concentrate - azoxystrobin pyrimidine active 250.0 g/l - fungicide - avocado | cucurbit | grape - destined for drying | grape - table | grape - wine | mango | passionfruit | poppy | potato | tomato - alternaria rot | anthracnose | base rot - rhizoctonia solani | botrytis cinerea | cladosporium | downy mildew | early blight (target spot) | late blight or irish blight | powdery mildew | sclerotinia minor | silver scurf | stem end rots | bottom rot - rhizoctonia | irish blight | target spot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - diflufenican - suspension concentrate - diflufenican anilide/aniline-nicotinanilide active 500.0 g/l - herbicide - established clover based pasture | field pea | lentil | lupin | poppy oilseed | drug poppy | oilseed poppy | opium poppy | pulse - amsinckia - suppression | capeweed - suppression | charlock | chickweed - suppression | corn gromwell - suppression | crassula - suppression | deadnettle | hedge or wild mustard | hyssop loosestrife - suppression | indian hedge mustard | marshmallow - suppression | mouse-ear chickweed - suppression | night-scented stock - suppression | paterson's curse - suppression | pheasant's-eye or adonis | prickly lettuce | rough poppy - suppression | shepherd's purse - suppression | skeleton weed - suppression | sorrel - suppression | speedwell (v. hederifolia) - suppression | stinging nettle - suppression | toad rush - suppression | turnip weed | wild or mediterranean turnip | wild radish or radish weed | wild turnip - brassica tournefortii | wireweed, hogweed - suppression | adonis annua | adonis dentatus | brassica kaber | brassica sinapistrum | buglossoides arvense | crambling mustard | giant mustard | hedge mustard | henbit deadnettle | iron weed | ivyleaf speedwell | ivyleaved speedwell | jointed charlock | knotwe